Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation

Neurology. 2017 Dec 12;89(24):2503-2505. doi: 10.1212/WNL.0000000000004747. Epub 2017 Nov 15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Female
  • Frontal Lobe / diagnostic imaging
  • Frontal Lobe / metabolism
  • Humans
  • Lipodystrophy / cerebrospinal fluid
  • Lipodystrophy / diagnostic imaging*
  • Lipodystrophy / genetics*
  • Membrane Glycoproteins / genetics*
  • Mental Status and Dementia Tests
  • Mutation*
  • Occipital Lobe / diagnostic imaging
  • Occipital Lobe / metabolism
  • Osteochondrodysplasias / cerebrospinal fluid
  • Osteochondrodysplasias / diagnostic imaging*
  • Osteochondrodysplasias / genetics*
  • Receptors, Immunologic / genetics*
  • Subacute Sclerosing Panencephalitis / cerebrospinal fluid
  • Subacute Sclerosing Panencephalitis / diagnostic imaging*
  • Subacute Sclerosing Panencephalitis / genetics*

Substances

  • Amyloid beta-Peptides
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM2 protein, human

Supplementary concepts

  • Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy